Loading...

Εκπαιδευτικά προγράμματα

Καταχωρήθηκε: Τρίτη 23 Οκτ 2018
1. The optimal time for MRD testing may depend on the type of MRD. CBFB-MYH11 AML displayed a slower clone regrowth than AML with the other molecular signatures and recommended MRD testing for CBFB-MYH11 be performed every 6 months, whereas testing for PML-RARA MRD was recommended for every 2 months.   2. Another subject of...
Καταχωρήθηκε: Δευτέρα 22 Οκτ 2018
We discussed a paper in which the authors measured MRD in AML by NGS  before allo Tx. They could perfom MRD analysis in most cases and MRD by  NGS proved the strongest factor for relapse post HCT. Presenter:  Prof. Spyridonidis Participants: Dr Liga, Dr Spyridis, Dr Lekka,...
Καταχωρήθηκε: Τετάρτη 17 Οκτ 2018
We updated the current options for the treatment of CNS NHL and reviewed a  patient series (5 pts) treated with nivolumab for rrCNS NHL. Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Spyridis, Dr Lekka, Dr Bountouris
Καταχωρήθηκε: Τρίτη 16 Οκτ 2018
The mechanisms of glucocorticoid induced leukocytosis were revealed during the discussion. TITLE: A general review of the mechanisms for steroid or glucocorticoid induced increases in the white blood cell count, Anthony J Busty, MD, PharmD, FNLA, FAHA.  Link: https://www.ebmconsult.com/articles/steroids-glucocorticoids-wbc-neutrophiles-increase Presenter:Dr Bountouris Participants: Prof. Spyridonidis, Dr Liga, Dr Spyridis,...
Καταχωρήθηκε: Τρίτη 16 Οκτ 2018
The treatment of DCIS T2N0M0 type of breast cancer was discussed and it was noted that after total mastectomy radiation is not needed. Presenter: Dr Bountouris Participants: Prof. Spyridonidis, Dr Liga, Dr Spyridis, Dr Lekka.
Καταχωρήθηκε: Τρίτη 16 Οκτ 2018
We discussed the evaluation and differential diagnosis of pineal tumors in adults, focusing on the pinocytomas.   Presenter: Dr Bountouris. Participants: Prof.Spyridonidis, Dr Liga, Dr Spyridis, Dr Lekka.
Καταχωρήθηκε: Δευτέρα 15 Οκτ 2018
The excellent review from Zeieser and  Blazar on chronic GvHD published  in NEJM was discussed. Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Spyridis, Dr Lekka, Dr Bountouris
Καταχωρήθηκε: Δευτέρα 15 Οκτ 2018
We discussed the central role of B cell activation in chronic GVHD and  discussed the results of ibrutinib in cGVHD which led to FDA approval. Presenter: Prof. Spyridonidis Participants. Dr Liga, Dr Spyridis, Dr Lekka, Dr Bountouris
Καταχωρήθηκε: Δευτέρα 15 Οκτ 2018
The excellent review from Zeieser and  Blazar on acute GvHD published in  NEJM was discussed. Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Spyridis, Dr Lekka, Dr Bountouris
Καταχωρήθηκε: Παρασκευή 12 Οκτ 2018
We reviewed a case of AML with 11q23 abnormality involving the MLL gene and discussed the indication for transplant.   Presenter: Prof. Spyridondis Particiaptns: Dr Liga, Dr Spyridis, Dr Lekka, Dr Bountouris  
Καταχωρήθηκε: Τετάρτη 10 Οκτ 2018
We presented a retrospective study showing that from patients not  receiveing alllo-HCT at CR-1, at 10 years 16.6% of patients aged <60  years and 2.4% of those aged ≥60 years were alive and disease-free. This  disease-free AML group consisted predominantly of patients with  core-binding factor AML with t(8;21)(q22;q22) or  inv(16)(p13q22)/t(16;16)(p13;q22) and...
Καταχωρήθηκε: Τρίτη 09 Οκτ 2018
Human herpesvirus 6 as a possible cause of pleuropericardial effusion in patients with hematologic malignacies after allogeneic transplantation.   Presenter: Dr Lekka Participants: Prof.Spyridonidis, Dr Liga, Dr Spyridis, Dr Bountouris
Καταχωρήθηκε: Τρίτη 09 Οκτ 2018
The study from the French group with positive results in gene therapy for Transfusion dependent Thalassemia patients was presented. We discussed the ended of conditioning in these patients with busulphan. Furthermore we discussed the need of busulphan levels in specific patients (eg children, thalssemia...
Καταχωρήθηκε: Τρίτη 09 Οκτ 2018
We discussed a case of isolated CNS relapse of an ALL ph + after BMT.  Interestingly the CNS relapse revealed with an AML clone. We discussed  the current literature. We specifically reviewed the cases in Table 3 of the paper attached. Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr...
Καταχωρήθηκε: Δευτέρα 08 Οκτ 2018
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation Presenter: Dr Spyridis  Participants: Prof.Spyridonidis, Dr Liga, Dr Lekka, Dr Bountouris
Καταχωρήθηκε: Τετάρτη 12 Σεπ 2018
If uncommon haplotype then a MUD search may be commited. Presenter: Prof.Spyridonidis Participants: Dr Liga, Dr Spyridis, Dr Lekka, Dr Bountouris
Καταχωρήθηκε: Τετάρτη 12 Σεπ 2018
A patient of ours with hhv6 viremia reveled pleuritis and pericardial infusion. Dr Lekka reviewed the literature and presented two case reports with hhv6 associated pericarditis. Presenter: Dr Lekka Participants: Prof.Spyridonidis, Dr Liga, Dr Spyridis, Dr Bountouris
Καταχωρήθηκε: Δευτέρα 03 Σεπ 2018
Έγινε παρουσίαση της Δημοσίευσης της εγκριτικής μελέτης του EPREX στο Leukemia 2018 και συζητηθηκε ο αλγοριθμος θεραπειας στα MDS low risk. Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Spyridis, Dr Aggelinas
Καταχωρήθηκε: Δευτέρα 03 Σεπ 2018
Two retrospective studies from EBMT and CIBMTR verified that  conditioning intensity plays a role in BMT for AML. We discussed the  terms myeloablative, RIC, RTC, NMA, lymphodepleting. Dr. Spyridonidis  presented his new (EBMT) intensity index. Presenter: Prof. Spyridondis Participants: Dr Liga, Dr Spyridis, Dr Aggelinas
Βρέθηκαν 279 αποτελέσματα. Σελίδα 7 από 14
Σελίδα << < [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] > >>
 

 

Τηλέφωνα Επικοινωνίας:

 

Γραμματεία MMMO: 2613 603506 (ασθενείς), 2613 604062 (Γραμματεία Διευθυντή) 
Fax : 2613 604066,
email (για ιατρούς): transplant@upatras.gr,
email (για ασθενείς): mmak@upatras.gr
email (για θέματα κλινικών μελετών) : gcppatras@gmail.com
Μονάδα Μεταμόσχευσης (Νοσηλεία): 2613 603 261
Γραφείο Ιατρών: 2613 604064, 2613 604065,
Εφημερεύων Ιατρός: 2610 999111 (τηλ. κέντρο ΠΓΝΠ)

 

βρείτε μας στο χάρτη

 

Login / Sitemap

 

© Copyright 2015 - 2021 Μονάδα Μεταμόσχευσης Μυελού των Οστών Πάτρας